Sageworth Trust Company of South Dakota’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
Sageworth Trust Company of South Dakota's HCAT Position: Q3 2022 in Review
Sageworth Trust Company of South Dakota sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 281 shares — an estimated $4K sold.
Sageworth Trust Company of South Dakota first reported a position in HCAT in Q4 2021 and held it in 3 quarters. The position peaked at $61K in Q4 2021. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.
- Sageworth Trust Company of South Dakota reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
- Sageworth Trust Company of South Dakota sold 281 Health Catalyst shares in Q3 2022, an estimated $4K.
- Sageworth Trust Company of South Dakota first reported a position in Health Catalyst in Q4 2021 and held it in 3 quarters.
- Sageworth Trust Company of South Dakota's Health Catalyst position peaked at $61K in Q4 2021.
- 171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.
Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.